EUVIMEDScopri EUVIMED
Open access · CC BY 4.0

Accelerated Endosomal Escape of Splice-Switching Oligonucleotides Enables Efficient Hepatic Splice Correction

Silvia Weiss iD, Simon Decker, Christoph Kugler, Laura Bocanegra Gómez, Helene Fasching iD, Denise Benisch, Fatih Alioglu, Levente Ferencz, Theresa Birkfeld, Filip Ilievski, Volker Baumann, Alina Duran and 13 more

ACS Applied Materials & Interfaces · 2025

DOI: 10.1021/acsami.4c19340 ↗

At a glance

Journal article in ACS Applied Materials & Interfaces, 2025. Written by Silvia Weiss and 24 co-authors. Institution: Faculty of Life Sciences, Department of Pharmaceutical Sciences, Laboratory of Macromolecular Cancer Therapeutics (MMCT), University of Vienna, Josef…. Major MEDLINE topics: Endosomes, Oligonucleotides, Liver, RNA Splicing. Cited 1 times so far (Crossref); 56 references. The full text is freely available (open access, CC BY 4.0). Funded by: FP7 Joint Technology Initiatives, ?sterreichische Forschungsf?rderungsgesellschaft, Universit?t Wien.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Splice-switching oligonucleotides (SSOs) can restore protein functionality in pathologies and are promising tools for manipulating the RNA-splicing machinery. Delivery vectors can considerably improve SSO functionality in vivo and allow dose reduction, thereby addressing the challenges of RNA-targeted therapeutics. Here, we report a biocompatible SSO nanocarrier, based on redox-responsive disulfide cross-linked low-molecular-weight linear polyethylenimine (cLPEI), for overcoming multiple biological barriers from subcellular compartments to en-route serum stability and finally in vivo delivery challenges. Intracellularly responsive cross-links of cLPEI significantly accelerated the endosomal escape and offered efficient SSO release to the cell's nucleus, thereby leading to high splice correction in vitro. In vivo performance of cLPEI-SSOs was investigated in a novel transgenic mouse model for splice correction, spatiotemporal tracking of SSO delivery in wild-type mice, and biodistribution in a colorectal cancer peritoneal metastasis model. A single intravenous application of 5 mg kg-1 cLPEI-SSOs induced splice correction in liver, lung, kidney, and bladder, giving functional protein, which was validated by RT-PCR. Near-infrared (NIR) fluorescence imaging and X-ray computed tomography revealed improved organ retention and reduced renal excretion of SSOs. NIR microscopy demonstrated the accumulation of SSOs in angiogenic tumors within the pancreas. Successful nuclear delivery of SSOs was observed in the hepatocytes. Thus, cLPEI nanocarriers resulted in highly efficient splice correction in vivo, highlighting the critical role of the enhanced SSO bioavailability.

Subjects

MeSH terms (MEDLINE)

EndosomesOligonucleotidesLiverRNA SplicingAnimalsMiceHumansPolyethyleneimineMice, TransgenicTissue Distribution

Author keywords

biological barrierscrosslinked polyethylenimineendosomal escapeintravenousoptical tomographyphosphorothioatesplice correction

Substances

OligonucleotidesPolyethyleneimine

Authors and institutions

  • Faculty of Life Sciences, Department of Pharmaceutical Sciences, Laboratory of Macromolecular Cancer Therapeutics (MMCT), University of Vienna, Josef-Holaubek-Platz 2, 1090 Vienna, Austria.
  • Institute of In-Vivo and In-Vitro Models, Biomodels Austria, Department of Biomedical Sciences, University of Veterinary Medicine Vienna, Veterinärplatz 1, A-1210 Vienna, Austria.
  • Department of Biomedical Sciences and Pathobiology, University of Veterinary Medicine Vienna and Ludwig Boltzmann Institute for Hematology and Oncology, Veterinärplatz 1, A-1210 Vienna, Austria.

ORCID profiles: Silvia Weiss, Helene Fasching, Ulrich Lächelt, Haider Sami, Manfred Ogris

Funding

  • FP7 Joint Technology Initiatives
  • ?sterreichische Forschungsf?rderungsgesellschaft
  • Universit?t Wien

Cite

APA

Weiss, S., Decker, S., Kugler, C., Gómez, L. B., Fasching, H., Benisch, D., Alioglu, F., Ferencz, L., Birkfeld, T., Ilievski, F., Baumann, V., Duran, A., Dusinovic, E., Follrich, N., Milenkovic, S., Mihalicokova, D., Paunov, D., Singeorzan, K., Zehetmayer, N., …, & Ogris, M. (2025). Accelerated Endosomal Escape of Splice-Switching Oligonucleotides Enables Efficient Hepatic Splice Correction. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.4c19340

Vancouver

Weiss S, Decker S, Kugler C, Gómez LB, Fasching H, Benisch D, et al. Accelerated Endosomal Escape of Splice-Switching Oligonucleotides Enables Efficient Hepatic Splice Correction. ACS Applied Materials & Interfaces. 2025. doi:10.1021/acsami.4c19340

BibTeX
@article{Weiss2025,
  author = {Weiss, Silvia and Decker, Simon and Kugler, Christoph and Gómez, Laura Bocanegra and Fasching, Helene and Benisch, Denise and Alioglu, Fatih and Ferencz, Levente and Birkfeld, Theresa and Ilievski, Filip and Baumann, Volker and Duran, Alina and Dusinovic, Enes and Follrich, Nadine and Milenkovic, Sandra and Mihalicokova, Dajana and Paunov, Daniel and Singeorzan, Karla and Zehetmayer, Nikolaus and Zivanonvic, Dejan and Lächelt, Ulrich and Boersma, Auke and Rülicke, Thomas and Sami, Haider and Ogris, Manfred},
  title = {Accelerated Endosomal Escape of Splice-Switching Oligonucleotides Enables Efficient Hepatic Splice Correction},
  journal = {ACS Applied Materials & Interfaces},
  year = {2025},
  doi = {10.1021/acsami.4c19340}
}
Start for free →